Sabaa International Company for Pharmaceutical and Chemical Industry (SIPC.CA)

Also known as:  Sabaa, Sabaa Pharma Group
Data delayed by 15 minutes
4.74 EGP 0.000.00%
As of 30 JUN 2020 - GMT|Egypt SE

Sabaa Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
-
P/E (Last 12 Month)
23.547
Upside
-
Target Price (Mean)
-
52Wk
2.65 19 MAR
6.19 21 JAN

Open
Data not available
Previous Close
4.74 EGP
Turnover
Data not available
EPS
0.201 EGP
Volume
0
Transactions
0
Market Cap
168.27M EGP
IPO Date
10-Oct-2013
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Sabaa International Company for Pharmaceutical and Chemical IndustryLast updated on: 25 January 2018

Business Summary
Manufacture of generic drugs.
Country of Incorporation
Ownership Type
Established In
2000
Primary Sector
Number of Employees
250
Stock Listing
IDStock TypeCurrencyExchangeSymbol
SIPC.CASEOrdinaryEGPEgypt SESIPC

Contact details

Primary address
Al Madaen Villa 6
Ahmed Shaker Street
Koliet Al Banat Area
413
Egypt
Heliopolis
CONTACT
Region
Cairo

WHO halts malaria drug in COVID-19 trials

The World Health Organization said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalized patients with COVID-19 after they failed to reduce mortality. This report produced by Jillian Kitchener.

Reuters Videos - Saturday 4 July 2020
All Health Care News

GCC IPO market could recover in H2

Saudi Arabia and the UAE will lead the IPO activity as eight IPOs are expected to be launched in the second half or by early 2021

Khaleej Times - 1 day ago
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Mr Sahel Morsi Mohammed Morsi Al Damrawi
Managing Director
Mr Sayid Abdulnabi Mohammed Al Bialy
Chief Executive Officer
Mr Mahrous Rabih
Finance Manager

Board Members

Mr Sayid Abdulnabi Mohammed Al Bialy
Chairman
Mr Sahel Morsi Mohammed Morsi Al Damrawi
Vice Chairman
Dr Mahmoud Abdulsalam Ahmad
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
CAIRO PHARMAC.36.010 EGP0.00
EGYPT INTL PHRM52.900 EGP0.00
ALX. PHARMACEUT.126.590 EGP0.00
MINAPHARM PHARMA81.700 EGP0.00
ARAB PHARM58.970 EGP0.00
GLAXO EGYPT14.600 EGP0.00
More

Sunday Outlook: COVID recovery vs COVID reality

Sunday Outlook: COVID recovery vs COVID reality

Oil falls below $43/bbl on virus fears

More

Most Viewed Stocks

Stock Screener

More